Monsenso

0.368

DKK

+5.14 %

MONSO

First North Denmark

Software

Technology

Less than 1K followers

+5.14%

0%

-7.54%

-41.12%

-21.37%

+30.58%

-67.34%

-

-93.94%

Monsenso operates in the IT sector. The company specializes in the provision of digital follow-up systems for care and nursing, as well as hospitals. The solutions are software-based and are mainly used for monitoring patients' health, as well as for internal monitoring and analysis. The largest operations are in the Nordic market. The head office is located in Copenhagen.

Market cap

24.52M DKK

Turnover

3.8K DKK

Revenue

9.62M

EBIT %

-60.29 %

P/E

-

Dividend yield-%

-

Financial calendar

7/3

2025

Annual report '24

10/4

2025

General meeting '25

29/8

2025

Interim report Q2'25

ShowingAll content types

Press release10/7/2024, 10:08 AM

Mental health app could help prevent depression in young people at high risk

Regulatory press release9/23/2024, 12:43 PM

Monsenso actively searches for strategic partnerships in Europe

Regulatory press release9/13/2024, 12:56 PM

Capital increase in Monsenso A/S as a result of warrants exercised by employees

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release8/29/2024, 6:30 AM

Monsenso presents H1 2024 report with a growth rate of 25%

Regulatory press release6/19/2024, 12:39 PM

Monsenso A/S changes Certified Adviser

Regulatory press release5/23/2024, 2:48 PM

Monsenso issues warrants to the deputy chairman of the board

Regulatory press release5/14/2024, 6:45 AM

Monsenso issues warrants to the deputy chairman of the board

Regulatory press release4/22/2024, 9:01 AM

Capital increase in Monsenso A/S as a result of warrants exercised by employees

Regulatory press release4/10/2024, 9:04 PM

Monsenso A/S issues warrants to management and employees

Regulatory press release3/6/2024, 7:28 AM

Monsenso presents annual report for 2023

Regulatory press release2/27/2024, 9:50 AM

Monsenso adjusts the expectations for 2023 and issues guidance for 2024

Regulatory press release12/14/2023, 8:52 AM

Carelink Group and Monsenso digitise nationwide mental health services offering

Regulatory press release11/1/2023, 2:15 PM

Monsenso signs new agreement with a leading pharmaceutical for a real-world data project in Denmark

Regulatory press release9/27/2023, 8:11 AM

Capital increase in Monsenso A/S as a result of warrants exercising of employees

Regulatory press release9/11/2023, 3:15 PM

Monsenso appoints COO Nanna Iversen to executive management

Regulatory press release9/7/2023, 6:45 AM

Monsenso presents H1 2023 report with a growth rate of 70%

Regulatory press release7/19/2023, 12:35 PM

Monsenso signs major new agreement with a European capital

Regulatory press release5/4/2023, 6:28 AM

Monsenso participates in MENTBEST - a European community-based and personalised digital intervention project

Regulatory press release3/28/2023, 6:15 AM

Artificial intelligence creates individually tailored treatment for depression

Regulatory press release3/24/2023, 7:42 PM

Monsenso A/S issues warrants to management and employees

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.